Years after bankruptcy, Dendreon adds a contract manufacturing wing

When CEO Jason O’Neill came aboard Dendreon just a year ago, he saw that the company was in a unique position: It occupied a rare space as one of the few end-to-end providers of cell therapy manufacturing services. And if it were to add a division of contract manufacturing arm...

Click to view original post